|
Histone acetylation blood biomarker for Alzheimer's Disease
2025-046: Histone Acetylation Blood Biomarker for Alzheimer’s Disease
Benefit
This technology introduces a fundamentally new diagnostic class: a blood-based assay that measures epigenetic enhancer activation rather than downstream neuronal damage. It enables clinicians and researchers to detect Alzheimer’s disease at its earliest molecular...
Published: 4/24/2026
|
Updated: 2/6/2026
|
Inventor(s): Andreas Pfenning, Easwaran Ramamurthy, Amulya Garimella
Keywords(s):
Category(s): Method or process
|